Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Accumulated Expenses (2020 - 2021)

Historic Accumulated Expenses for Design Therapeutics (DSGN) over the last 2 years, with Q2 2021 value amounting to $1.8 million.

  • Design Therapeutics' Accumulated Expenses changed N/A to $1.8 million in Q2 2021 from the same period last year, while for Jun 2021 it was $1.8 million, marking a year-over-year change of. This contributed to the annual value of $931000.0 for FY2020, which is N/A changed from last year.
  • Latest data reveals that Design Therapeutics reported Accumulated Expenses of $1.8 million as of Q2 2021.
  • Design Therapeutics' 5-year Accumulated Expenses high stood at $1.8 million for Q2 2021, and its period low was $931000.0 during Q4 2020.